Rapid response of retinal pigment epithelial detachments to intravitreal aflibercept in neovascular age-related macular degeneration refractory to bevacizumab and ranibizumab-Reference-Cited by-同舟云学术

Rapid response of retinal pigment epithelial detachments to intravitreal aflibercept in neovascular age-related macular degeneration refractory to bevacizumab and ranibizumab

Published:2013-04-05 Issue:5 Volume:27 Page:663-668
ISSN:0950-222X
Container-title:Eye
language:en
Short-container-title:Eye

Author:

Patel K H,Chow C C,Rathod R,Mieler W F,Lim J I,Ulanski L J,Leiderman Y I,Arun V,Chau F Y

Publisher

Springer Science and Business Media LLC

Subject

Ophthalmology

Link

http://www.nature.com/articles/eye201331.pdf

Reference13 articles.

1. Coscas F, Coscas G, Souied E, Tick S, Soubrane G . Optical coherence tomography identification of occult choroidal neovascularization in age-related macular degeneration. Am J Ophthalmol 2007; 144 (4): 592–599.

2. Pepple K, Mruthyunjaya P . Retinal pigment epithelial detachments in age-related macular degeneration: classification and therapeutic options. Semin Ophthalmol 2011; 26 (3): 198–208.

3. Macular Photocoagulation Study Group. Laser photocoagulation of subfoveal neovascular lesions in age-related macular degeneration. Results of a randomized clinical trial. Arch Ophthalmol 1991; 109 (9): 1220–1231.

4. Arias L . Treatment of retinal pigment epithelial detachment with antiangiogenic therapy. Clin Ophthalmol 2010; 4: 369–374.

5. Rosenfeld PJ, Brown DM, Heier JS, Boyer DS, Kaiser PK, Chung CY et alMARINA Study Group. Ranibizumab for neovascular age-related macular degeneration. N Engl J Med 2006; 355 (14): 1419–1431.

Cited by 74 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Granzyme B degrades extracellular matrix and promotes inflammation and choroidal neovascularization;Angiogenesis;2024-03-18

2. Brolucizumab for recalcitrant macular neovascularization in age-related macular degeneration with pigment epithelial detachment;European Journal of Ophthalmology;2023-07-18

3. Faricimab Effectively Resolves Intraretinal Fluid and Preserves Vision in Refractory, Recalcitrant, and Nonresponsive Neovascular Age-Related Macular Degeneration;Cureus;2023-06-07

4. Response of extra-large pigment epithelial detachment to intravitreal brolucizumab injection;American Journal of Ophthalmology Case Reports;2023-06

5. Brolucizumab intravitreal injection in macular neovascularization type 1: VA, SD-OCT and OCTA parameters changes during a 16-weeks follow up;Ophthalmic Research;2022-09-26